Nerudia was established in 2013 to support the rapidly developing nicotine products industry with high quality manufacturing services and to provide scientific support to characterise our customers’ products within a single regulated facility.
Serving the electronic cigarette, NRT, and novel nicotine delivery technology industries, we help our customers bring quality products to the market and at the same time guide them through the regulatory pathways for these novel products.
We are committed to working in partnership with you to deliver value for money products and services. Our service levels, consistency, and drive to constantly improve quality, combined with our innovation and expertise, will help your business grow. Our success will be measured through your successes.
Confidentiality is our top product.
Originally founded by industry pioneers David Newns and Chris Lord, Nerudia is now part of Fontem Ventures, an innovative consumer goods company in the Imperial Brands PLC portfolio.
David and Chris have been involved in the electronic cigarette industry since 2008 when they founded CN Creative and developed the Intellicig brand.
David, who was identified in the ‘Top 50 Young Entrepreneurs to Watch’ in 2009, has been in the Nicotine Products industry since 2008 when he built the CN Creative business with his business partner Chris Lord. Together they co-founded Nerudia in 2013; a business that will be seen as the world's leading authority on nicotine products and next generation products for e-cigarettes.
David has brought his and Chris’s vision and strategy for Nerudia to life. He has achieved this by building a world-class team of scientists and operational and commercial managers. This enables Nerudia to support its customers to achieve their growth plans in this rapidly expanding global market. David’s entrepreneurial spirit is a fundamental driver of the development of the Nerudia brand and businesses which have quickly achieved international status.
Chris has twenty years' experience in the medical device industry designing innovative engineering solutions. At CN Creative he was fundamental in developing Nicadex which was awarded a CE mark in December 2012, and became the world’s first medically approved e-cigarette under the e-voke brand in 2015.
As the co-founder of Nerudia, Chris’s development of innovative products and processes brings another unique layer to the Nerudia business. Original in his thinking, he is seen as naturally innovative and skilled at bringing multi-disciplinary teams together.